{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:31:01Z","timestamp":1772134261346,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.micpath.2021.105088","type":"journal-article","created":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T09:31:54Z","timestamp":1625995914000},"page":"105088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The role of IL-32 in Bacillus Calmette-Gu\u00e9rin (BCG)-induced trained immunity in infections caused by different Leishmania spp."],"prefix":"10.1016","volume":"158","author":[{"given":"Muriel Vilela Teodoro","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9ssica Cristina","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Marina Barroso de","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa U.","family":"Teufel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0826-4348","authenticated-orcid":false,"given":"Jonathas Xavier","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazzielle Guimar\u00e3es de","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasti\u00e3o Alves","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9551-9419","authenticated-orcid":false,"given":"Rodrigo Saar","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-9830","authenticated-orcid":false,"given":"Leo A.B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Ribeiro-Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.105088_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.105088_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/S0037-86822003000100011","article-title":"American cutaneous leishmaniasis","volume":"36","author":"Gontijo","year":"2003","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.micpath.2021.105088_bib3","doi-asserted-by":"crossref","first-page":"18689","DOI":"10.1074\/jbc.M117.796912","article-title":"IRAK4 kinase activity controls Toll-like receptor\u2013induced inflammation through the transcription factor IRF5 in primary human monocytes","volume":"292","author":"Cushing","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2021.105088_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061296","article-title":"Cutaneous manifestations of human and murine leishmaniasis","volume":"18","author":"Scorza","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2021.105088_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0074-02762004000300009","article-title":"Leishmania braziliensis: partial control of experimental infection by interleukin-12 p40 deficient mice","volume":"99","author":"de Souza-Neto","year":"2004","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2021.105088_bib6","first-page":"293","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"26","author":"Goto","year":"2012","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.micpath.2021.105088_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-407679-2.00005-3","article-title":"Mechanisms of immune evasion in leishmaniasis","volume":"82","author":"Gupta","year":"2013","journal-title":"Adv. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2021.105088_bib8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1468-3083.2009.03238.x","article-title":"Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil","volume":"23","author":"Amato","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"3","key":"10.1016\/j.micpath.2021.105088_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.2009.81.378","article-title":"Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG\/Leishmania antigens","volume":"81","author":"Pereira","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.micpath.2021.105088_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J. Urol."},{"key":"10.1016\/j.micpath.2021.105088_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003958","article-title":"Immunogenic properties of a BCG adjuvanted chitosan nanoparticle-based dengue vaccine in human dendritic cells","volume":"9","author":"Hunsawong","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2021.105088_bib12","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1080\/21645515.2017.1316911","article-title":"Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity","volume":"13","author":"Mahant","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2021.105088_bib13","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/bju.14793","article-title":"The epidemiology of bacille Calmette\u2013Gu\u00e9rin infections after bladder instillation from 2002 through 2017: a nationwide retrospective cohort study","volume":"124","author":"Larsen","year":"2019","journal-title":"BJU Int."},{"key":"10.1016\/j.micpath.2021.105088_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/iai.16.1.249-257.1977","article-title":"Effect of treatment with BCG on the course of visceral Leishmaniasis in BALB\/c mice","volume":"16","author":"Smrkovski","year":"1977","journal-title":"Infect. Immun."},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2021.105088_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1590\/S0074-02761992000500010","article-title":"Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine","volume":"87","author":"Calabrese","year":"1992","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2021.105088_bib16","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1128\/iai.55.7.1707-1714.1987","article-title":"Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice","volume":"55","author":"Fortier","year":"1987","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.105088_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5152\/tpd.2013.2988","article-title":"Post challenging serum cytokine profile (Th1 & Th2) in the vaccinated mice (Balb\/C) with a new formulation of Leishmania major antigen","volume":"37","author":"Latifynia","year":"2013","journal-title":"Turk. Parazitoloji Derg."},{"key":"10.1016\/j.micpath.2021.105088_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00436-013-3716-5","article-title":"Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis","volume":"113","author":"Khare","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2021.105088_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(87)90116-4","article-title":"Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis","volume":"329","author":"Convit","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2021.105088_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0074-02762004000100010","article-title":"Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and Bacillus Calmette-Guerin - preliminary report","volume":"99","author":"Convit","year":"2004","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2021.105088_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0264-410X(98)00220-5","article-title":"A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran","volume":"17","author":"Momeni","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.105088_bib22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0035-9203(00)90239-6","article-title":"Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: arandomized controlled trial","volume":"94","author":"V\u00e9lez","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.micpath.2021.105088_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/S0037-86822006000100003","article-title":"Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment","volume":"39","author":"Mayrink","year":"2006","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.micpath.2021.105088_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-3024.1989.tb00660.x","article-title":"Cell\u2010mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy","volume":"11","author":"Castes","year":"1989","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2021.105088_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trstmh.2007.08.006","article-title":"Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment","volume":"102","author":"Musa","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.micpath.2021.105088_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: implication for vaccine design","volume":"10","author":"Covi\u00e1n","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.105088_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2021.105088_bib28","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.micpath.2021.105088_bib29","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.micpath.2021.105088_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/08830185.2020.1712379","article-title":"BCG-induced trained immunity in macrophage: reprograming of glucose metabolism: BCG-induced trained immunity by enhanced glycolysis and glutamine-driven tricarboxylic acid cycle in macrophage","volume":"39","author":"Liu","year":"2020","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.micpath.2021.105088_bib31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","article-title":"BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment","volume":"28","author":"Cirovic","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2021.105088_bib32","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.micinf.2014.08.015","article-title":"Essential role of leukotriene B4 on Leishmania (Viannia) braziliensis killing by human macrophages","volume":"16","author":"Morato","year":"2014","journal-title":"Microb. Infect."},{"key":"10.1016\/j.micpath.2021.105088_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00281-012-0350-8","article-title":"Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis","volume":"34","author":"Soong","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.micpath.2021.105088_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2020.102097","article-title":"IL-15 enhances the capacity of primary human macrophages to control Leishmania braziliensis infection by IL-32\/vitamin D dependent and independent pathways","volume":"76","author":"Silva","year":"2020","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.micpath.2021.105088_bib35","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1371\/journal.pmed.0030277","article-title":"Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1\/IL-18\/Interferon-\u03b3-Dependent mechanism","volume":"3","author":"Netea","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.micpath.2021.105088_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2334-14-249","article-title":"Interleukin 32\u03b3 (IL-32\u03b3) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10","volume":"14","author":"Galdino","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2021.105088_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-017-2268-4","article-title":"IL-32\u03b3 promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis","volume":"10","author":"Gomes","year":"2017","journal-title":"Parasites Vectors"},{"issue":"2","key":"10.1016\/j.micpath.2021.105088_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005413","article-title":"Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species","volume":"11","author":"dos Santos","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"5","key":"10.1016\/j.micpath.2021.105088_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00796-17","article-title":"Human interleukin-32\u03b3 plays a protective role in an experimental model of visceral leishmaniasis in mice","volume":"86","author":"Gomes","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.105088_bib40","doi-asserted-by":"crossref","first-page":"21082","DOI":"10.1073\/pnas.1015418107","article-title":"Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis","volume":"107","author":"Choi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.micpath.2021.105088_bib41","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.celrep.2019.08.004","article-title":"\u03b2-Glucan-Induced trained immunity protects against Leishmania braziliensis infection: a crucial role for IL-32","volume":"28","author":"dos Santos","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.micpath.2021.105088_bib42","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/CVI.00349-16","article-title":"In Vitro experimental model of trained innate immunity in human primary monocytes","volume":"23","author":"Bekkering","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2021.105088_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15412-7","article-title":"The NOD2 receptor is crucial for immune responses towards New World Leishmania species","volume":"7","author":"Dos Santos","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2021.105088_bib44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0022-1759(03)00231-X","article-title":"Simple and cost-effective isolation of monocytes from buffy coats","volume":"278","author":"Repnik","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.micpath.2021.105088_bib45","article-title":"Laboratory maintenance of Bartonella quintana","author":"Trache","year":"2008","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.micpath.2021.105088_bib46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/abio.1987.9999","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate\u2013phenol\u2013chloroform extraction","volume":"162","author":"Chomzynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.micpath.2021.105088_bib47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2153-3539.109804","article-title":"A free software toolkit for histopathological cell counting and staining estimation","volume":"4","author":"Wild","year":"2013","journal-title":"J. Pathol. Inf."},{"key":"10.1016\/j.micpath.2021.105088_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftx082","article-title":"Platelet-activating factor increases reactive oxygen species-mediated microbicidal activity of human macrophages infected with Leishmania (Viannia) braziliensis","volume":"75","author":"Borges","year":"2017","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.micpath.2021.105088_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-3024.2009.01116.x","article-title":"Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis","volume":"31","author":"Silveira","year":"2009","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2021.105088_bib50","doi-asserted-by":"crossref","first-page":"393049","DOI":"10.1155\/2015\/393049","article-title":"In vitro metacyclogenesis of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis clinical field isolates, as evaluated by morphology, complement resistance, and infectivity to human macrophages","volume":"2015","author":"da Silva","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2021.105088_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005413","article-title":"Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species","volume":"11","author":"dos Santos","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2021.105088_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12026-014-8535-y","article-title":"Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms","volume":"59","author":"Martinez","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.micpath.2021.105088_bib53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.vetpar.2008.09.015","article-title":"Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis","volume":"158","author":"Pereira","year":"2008","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.micpath.2021.105088_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-065X.2007.00559.x","article-title":"Unveiling pathways used by Leishmania amazonensis amastigotes to subvert macrophage function","volume":"219","author":"Osorio Y Fort\u00e9a","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.micpath.2021.105088_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.imlet.2009.08.009","article-title":"NF-\u03baB-mediated repression of iNOS expression in Leishmania amazonensis macrophage infection","volume":"127","author":"Calegari-Silva","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micpath.2021.105088_bib56","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-3024.2012.01384.x","article-title":"Leishmania amazonensis fails to induce the release of reactive oxygen intermediates by CBA macrophages","volume":"34","author":"Almeida","year":"2012","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2021.105088_bib57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pt.2012.05.002","article-title":"Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival","volume":"28","author":"Ueno","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.micpath.2021.105088_bib58","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1462-5822.2009.01374.x","article-title":"Differences in human macrophage receptor usage, lysosomal fusion kinetics and survival between logarithmic and metacyclic Leishmania infantum chagasi promastigotes","volume":"11","author":"Ueno","year":"2009","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.micpath.2021.105088_bib59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cyto.2016.09.009","article-title":"Leishmania (Viannia) braziliensis amastigotes induces the expression of TNF\u03b1 and IL-10 by human peripheral blood mononuclear cells in vitro in a TLR4-dependent manner","volume":"88","author":"Galdino","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.micpath.2021.105088_bib60","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.4049\/jimmunol.0803720","article-title":"Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection","volume":"183","author":"Novais","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2021.105088_bib61","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.4049\/jimmunol.0802860","article-title":"IFN-\u03b2 impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis","volume":"182","author":"Khouri","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2021.105088_bib62","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","article-title":"IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1\u03b2 and IL-6 production through a caspase 1-dependent mechanism","volume":"102","author":"Netea","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.micpath.2021.105088_bib63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00436-004-1193-6","article-title":"Immune response induced by New World Leishmania species in C57BL\/6 mice","volume":"94","author":"Maioli","year":"2004","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2021.105088_bib64","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/IAI.01335-06","article-title":"Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice","volume":"75","author":"Rocha","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.105088_bib65","first-page":"1059","article-title":"Biological behavior of Leishmania (L.) amazonensis isolated from a human diffuse cutaneous leishmaniasis in inbred strains of mice","volume":"18","author":"Cupolilo","year":"2003","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.micpath.2021.105088_bib66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4269\/ajtmh.2003.68.661","article-title":"Central nervous system involvement in experimental infection with Leishmania (Leishmania) amazonensis","volume":"68","author":"Abreu-Silva","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.micpath.2021.105088_bib67","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4269\/ajtmh.1986.35.732","article-title":"Isolation of Leishmania mexicana amazonensis from the bone marrow in a case of American visceral leishmaniasis","volume":"35","author":"Barral","year":"1986","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.micpath.2021.105088_bib68","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2021.105088_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009546","article-title":"IL-32 is a molecular marker of a host defense network in human tuberculosis","volume":"6","author":"Montoya","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.micpath.2021.105088_bib70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsbmb.2018.01.002","article-title":"In vivo response of the human epigenome to vitamin D: a Proof-of-principle study","volume":"180","author":"Carlberg","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.micpath.2021.105088_bib71","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.micpath.2021.105088_bib72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trsl.2017.10.004","article-title":"Macrophage polarization and meta-inflammation","volume":"191","author":"Li","year":"2018","journal-title":"Transl. Res."},{"key":"10.1016\/j.micpath.2021.105088_bib73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2334-14-249","article-title":"Interleukin 32\u03b3 (IL-32\u03b3) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10","volume":"14","author":"Galdino","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2021.105088_bib74","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-3024.2012.01372.x","article-title":"Are the severe injuries of cutaneous leishmaniasis caused by an exacerbated Th1 response?","volume":"34","author":"Nicodemo","year":"2012","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2021.105088_bib75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0001-706X(02)00260-7","article-title":"Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment","volume":"85","author":"Amato","year":"2003","journal-title":"Acta Trop."},{"issue":"6","key":"10.1016\/j.micpath.2021.105088_bib76","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2340\/0001555559547549","article-title":"Induction of delayed-type sensitivity to Leishmania parasite in a case of leishmaniasis cutanea diffusa with BCG and cord-factor (Trehalose-6-6\u2019 dimycolate)","volume":"59","author":"Cohen","year":"1979","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.micpath.2021.105088_bib77","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/infdis\/160.1.104","article-title":"Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis","volume":"160","author":"Convil","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.105088_bib78","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","article-title":"Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran","volume":"351","author":"Sharifi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2021.105088_bib79","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.2009.81.378","article-title":"Case report: increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG\/Leishmania antigens","volume":"81","author":"Pereira","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.micpath.2021.105088_bib80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/rccm.201104-0714OC","article-title":"The influence of bacille Calmette-Gu\u00e9rin vaccine strain on the immune response against tuberculosis: a randomized trial","volume":"185","author":"Ritz","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.micpath.2021.105088_bib81","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.vaccine.2019.11.060","article-title":"Licensed Bacille Calmette-Gu\u00e9rin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation","volume":"38","author":"Angelidou","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.105088_bib82","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1128\/IAI.00244-07","article-title":"Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Gu\u00e9rin","volume":"75","author":"Wu","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.105088_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2021.04.028","article-title":"Comparing cytokine production and clinical response following vaccination with BCG Moreau and BCG Russia strains in a Brazilian infant population","author":"Bitencourt","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.105088_bib84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0001-706X(02)00260-7","article-title":"Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment","volume":"85","author":"Amato","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.micpath.2021.105088_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006164","article-title":"Changing demographics of visceral leishmaniasis in northeast Brazil: lessons for the future","volume":"12","author":"Lima","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2021.105088_bib86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/expr.1999.4459","article-title":"BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice","volume":"94","author":"Streit","year":"2000","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2021.105088_bib87","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(02)00444-9","article-title":"IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis","volume":"21","author":"Santos","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.105088_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00315-X","article-title":"A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum","volume":"92","author":"Molano","year":"2003","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.micpath.2021.105088_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-10-181","article-title":"Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis","volume":"10","author":"Ravindran","year":"2010","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2021.105088_bib90","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00431-18","article-title":"Limited pulmonary mucosal-associated invariant T cell accumulation and activation during Mycobacterium tuberculosis infection in rhesus macaques","volume":"86","author":"Kauffman","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.105088_bib91","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/BF01959951","article-title":"Leishmania donovani in hamsters: stimulation of non-specific resistance by some novel glycopeptides and impact on therapeutic efficacy","volume":"47","author":"Pal","year":"1991","journal-title":"Experientia"},{"key":"10.1016\/j.micpath.2021.105088_bib92","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF01941270","article-title":"Leishmania donovani in hamsters: stimulation of non-specific resistance by novel lipopeptides and their effect in antileishmanial therapy","volume":"51","author":"Zehra","year":"1995","journal-title":"Experientia"},{"key":"10.1016\/j.micpath.2021.105088_bib93","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2007.02.083","article-title":"Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial","volume":"25","author":"Lemesre","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.105088_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01202","article-title":"Characterizing the BCG induced macrophage and neutrophil mechanisms for defense against Mycobacterium tuberculosis","volume":"11","author":"Bickett","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.105088_bib95","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.90.24.11473","article-title":"Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63","volume":"90","author":"Connell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.micpath.2021.105088_bib96","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0264-410X(94)90342-5","article-title":"Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: skin-test reactivity, T-cell proliferation and interferon-\u03b3 production","volume":"12","author":"Cast\u00e9s","year":"1994","journal-title":"Vaccine"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021003600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021003600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:39:44Z","timestamp":1760110784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021003600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":96,"alternative-id":["S0882401021003600"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105088","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of IL-32 in Bacillus Calmette-Gu\u00e9rin (BCG)-induced trained immunity in infections caused by different Leishmania spp.","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105088"}}